Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-7-5
pubmed:abstractText
This study investigates the long-term angiogenic effects of ANG-1 and VEGF in a swine chronic myocardial ischemia model. Four-weeks after gradual occlusion of the left circumflex coronary artery by ameroid constrictor, animals were injected with recombinant adenoviral vectors carrying either human ANG-1 (n=9), human VEGF(165) (n=10) or empty vector (n=7) into the left ventricle free wall supplied by the constricted artery. Left ventricular perfusion in animals that received AdANG-1 (3.25+/-0.16 ml/min/g, p<0.05) recovered robustly 4 weeks after gene transfer while ischemia persisted in the AdVEGF (1.09+/-0.13 ml/min/g) and empty vector (1.20+/-0.03 ml/min/g) groups. Microvascular densities in the left ventricles of animals that received AdANG-1 (19.61+/-1.76/0.572 mm(2) myocardial tissue, p<0.05) and AdVEGF (18.17+/-1.43/0.572 mm(2) myocardial tissue, p<0.05) were significantly higher than animals that received empty vector (13.53+/-0.92/0.572 mm(2) myocardial tissue) 12 weeks after gene transfer. ANG-1, but not VEGF, contributed to enhanced regional perfusion by increasing arteriolar density (1.9+/-0.4/0.572 mm(2) myocardial tissue vs. 0.7+/-0.2/0.572 mm(2) myocardial tissue, p<0.05) of large-sized (50-100 microm) arterioles. These data demonstrate that gene transfer of ANG-1 and VEGF enhances angiogenesis, but ANG-1 promotes sustained improvement of ventricular perfusion that expedites recovery of ischemic myocardium via arteriogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1021-7770
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
579-91
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16547766-Adenoviridae, pubmed-meshheading:16547766-Analysis of Variance, pubmed-meshheading:16547766-Angiopoietin-1, pubmed-meshheading:16547766-Animals, pubmed-meshheading:16547766-Coronary Angiography, pubmed-meshheading:16547766-Coronary Circulation, pubmed-meshheading:16547766-Coronary Vessels, pubmed-meshheading:16547766-DNA Primers, pubmed-meshheading:16547766-Gene Therapy, pubmed-meshheading:16547766-Genetic Vectors, pubmed-meshheading:16547766-Humans, pubmed-meshheading:16547766-Immunohistochemistry, pubmed-meshheading:16547766-Myocardial Ischemia, pubmed-meshheading:16547766-Myocardial Reperfusion, pubmed-meshheading:16547766-Neovascularization, Physiologic, pubmed-meshheading:16547766-Regional Blood Flow, pubmed-meshheading:16547766-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16547766-Swine, pubmed-meshheading:16547766-Vascular Endothelial Growth Factor A
pubmed:year
2006
pubmed:articleTitle
Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model.
pubmed:affiliation
Research and Development Unit, National Heart Center, 17 Third Hospital Avenue, Singapore 168752, Singapore. winston_shim_sn@nhc.com.sg
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't